Addressing Health Inequities With RWE: Not Just Lip Service
One of the most vexing problems in healthcare today is the persistence of health inequities that deprive minority ...
Published by Sandy Bonfin, PharmD, BCPS on May 5, 2022 11:07:00 AM
Medication-related problems (MRPs) are issues caused by prescription medications that can interfere with a patient’s health or therapy goals.
Older adults, in particular, are more at risk for MRPs. Medications prescribed to older adults represent 33% of all medications prescribed. The average older adult takes eight medications daily. This phenomenon, called polypharmacy, puts older adults at higher risk of experiencing problems such as treatment failure or adverse drug reactions.
The costs of medication-related problems are staggering. They have become a leading cause of death in the US, and up to 750 older adults are hospitalized per day for issues related to non-optimized medications. They are also a leading cause of avoidable hospital admissions and emergency department visits, reducing quality of life and diverting valuable dollars to avoidable healthcare costs.
MRPs carry a heavy financial toll for plans, providers, and patients. In the United States, the total cost of non-optimized medications and the subsequent medication problems was estimated at $528 billion in 2016, or 16% of all US healthcare expenditures.
Medication-related problems do more than hurt wallets. Patients feel the effects physically as much as financially, experiencing more health problems, taking more trips to the hospital, and struggling to achieve their health goals.
Older adults, in particular, because of their age, experience more health problems and chronic medical conditions, resulting in more visits to the doctor. Care for chronic conditions is often pushed out to specialty healthcare professionals who provide care in silos. In this fractured, uncoordinated care delivery system, patients are at increased risk of medication errors. As a result, patients with chronic conditions, like congestive heart failure (CHF), hypertension or dementia are more affected by medication-related problems, including drug-drug interactions, drug-disease interactions, ineffective drug therapy, or reduced quality of life. One study found that 93% of patients with dementia had at least one MRP, like falls with injury or drug toxicity and higher health care costs.
Even when the right medications in the right dose are prescribed for the right reasons, medication-related problems are prevalent in the older population. The sheer volume of pills ingested on a daily basis can create confusion and errors on the part of the patient. Coordinating refills for eight or more medications (often across multiple pharmacies) can be challenging and result in medication-related problems and adherence issues. In a 2019 study published in the Journal of Managed Care and Specialty Pharmacy, researchers found that Medicare Part D beneficiaries taking more than 11 medications were twice as likely to experience drug-related problems as those taking fewer medications, potentially causing unnecessary hospitalizations and costly emergency department visits.
Solving the costs of medication-related problems starts with understanding why they happen in the first place.
Inappropriate medication selection happens when a patient is not on the best medication to treat their health conditions. It also occurs when the medication prescribed isn’t optimal based on their age, other disease states they may have and other medications they may take. Inappropriate drug selection happens in two main ways:
In underprescribing, providers fail to prescribe medications to patients that need them. For example, laxatives may be underprescribed to a patient taking opioids. Or angiotensin-converting enzyme inhibitors (ACEIs) can be underprescribed in patients with CHF.
In overprescribing, patients may be taking a medication when it is not indicated. For example, perhaps the medication was originally intended to treat an acute condition, but the prescription was never stopped when the condition resolved. Or, in other cases, a provider may prescribe a medication to treat the side effect of another medication instead of managing that side effect by optimizing or discontinuing the first medication.
Even when patients take the correct medications, their doses may not be optimized, which leads to treatment failure.
For example, in a study published in the Joint Commission Journal on Quality and Patient Safety, fewer than half of patients in the study, about 45%, were prescribed the appropriate doses of therapies for heart failure. Most patients were underdosed, despite the well-established fact that medication titration in heart failure can reduce mortality, reduce heart failure hospitalizations, and improve quality of life.
One study in the Journal of American College of Cardiology looked at patients on direct oral anticoagulants (DOACs) for stroke prevention. Almost half of patients with renal impairment were potentially overdosed, putting them at a higher risk of bleeding. Another 10% of patients with normal renal function were underdosed, increasing their risk of stroke.
For some patients, medication-related problems are caused by interactions between their disease states and the medications they take. Examples of serious drug-disease interactions that can cause MRPs in older patients include the following:
Another common cause of medication-related problems is drug-drug interactions. Like drug-disease interactions, drug-drug interactions are more common in older adults due to age-related physiological changes, higher incidence of multiple disease states, and medication use. As a result, drug-drug interactions put older adults at an elevated risk of hospitalization. Examples of medication-related problems due to drug-drug interactions include the following:
Drug monitoring includes monitoring the achievement of the goals of therapy (controlled blood pressure, controlled blood sugar), checking for adverse effects of the therapy, performing necessary lab tests to check the efficacy of the therapy (lipid tests, metabolic panels, drug levels), and regularly re-assessing the need for medication.
When patients receive inadequate monitoring, they could experience therapeutic inertia and MRPs like adverse drug reactions, drug-drug interaction, and therapy failure.
Patient non-adherence is often cited as the main reason for medication-related problems.
According to the World Health Organization, medication adherence in people with chronic diseases averages 50% in developed countries. Low adherence can be due to different factors:
But, medication adherence is not the only factor that causes medication-related problems. If medications aren’t indicated, effective, or safe for a patient, asking them to adhere can be dangerous or even deadly.
MRPs also result from communication breakdowns as the older adult transitions from one care team to another.
In the doctor’s office, providers may not educate patients properly on their conditions and therapies, patients may mishear or forget, they may not comprehend the information they are provided, or they may have language barriers preventing them from understanding instructions.
At the pharmacy, patients may not receive counseling from their pharmacists due to the busy environment of retail pharmacies. Additionally, patients may also see different providers and fill their prescriptions at different pharmacies, with each provider or pharmacy unaware of the other, leading to duplication of therapy.
Mistakes can be made during the medication reconciliation process when a patient is admitted to the hospital. This can lead patients to continue taking medications that they were supposed to stop or miss medications they’re supposed to be on during their admission.
Patients and caregivers may not be educated properly on medications that were stopped or started during admission. New medications that were started in the hospital to treat an acute condition may be continued by mistake at discharge.
The patient care team may not be informed of therapy changes that were made during the patient's hospital stay, and the patient may take medications that are no longer needed or miss medications that are critical to their treatment.
With healthcare moving more toward a value-based model, stakeholders have looked for innovative solutions to improve health outcomes and decrease costs. With the staggering costs associated with them, medication-related problems present a monumental opportunity.
The good news is that the health and economic costs of MRPs are entirely preventable. Armed with cutting-edge technology and tools, care teams can stop medication-related problems before they happen.
Health plans and providers collect mountains of data every day that can be used to identify drug interactions and adverse drug effects early. Arine’s platform ingests and analyzes data from multiple sources including electronic medical records, prescription, and medical claims data, costs data, quality data, social determinants of health data, and digital device data. The platform analyzes this data and creates comprehensive data insights to help care teams intervene proactively and efficiently to prevent medication-related problems.
For example, one older patient had a history of frequent hospital admissions and diagnoses of CHF, COPD, and chest pain. He had not seen his primary care physician recently. Arine analyzed multidimensional data to identify that the patient was at risk for a medication-related problem and created a personalized care plan to help him get on the right medications. As a result, his clinical team optimized his CHF medications, triaged him to a smoking cessation program, and connected him to transportation to his physician. During the follow-up year, the patient stayed out of the hospital.
Care teams can also leverage automation, machine learning, and predictive analytics to prevent MRPs.
AI-driven technology can connect and synthesize all of a patient’s data and automate manual work for the care team, such as automatically creating care plans, generating patient and provider communication letters, and assigning tasks to the appropriate person on the care team.
Adding predictive analytics to the care team’s tool chest can help identify when high-risk, high-cost events will occur and enable care teams to get the right care to the right patient at the right time.
Technology that learns from the result of every care team intervention can give health plans and providers the insight they need to understand what works and what doesn’t for their population and continuously optimize their care delivery.
Technology that automatically integrates the whole patient picture of social, behavioral and clinical risk factors along with evidence-based guidelines can help improve appropriate drug selection, address overprescribing or underprescribing, optimize medication doses and decrease therapeutic inertia.
For instance, Arine’s AI-powered medication intelligence platform integrates current clinical guidelines into its algorithms to create evidence-based care plans and automatically generate patients' education and physician recommendations considering the unique patient needs. Care teams using the platform have all the information they need at their fingertips and can spend less time searching for guidelines to apply to patient care and more time counseling patients. Integration of guidelines also improves the standard of care, allowing clinicians to deliver the same high level of care as a clinician with years of experience.
Healthcare providers and payers can come together to prevent medication-related problems. When you equip your care teams with the right tools, they can quickly scale care that prevents medication-related problems before they happen.
Register for our on-demand webinar to see how Arine incorporates AI to deliver comprehensive medication management and reduce medication-related problems.
One of the most vexing problems in healthcare today is the persistence of health inequities that deprive minority ...
Medication mismanagement costs the United States healthcare system $1 in every $6. In the arduous trek to value-based ...
Pharmaceutical advancements have played a major role in improving the United States’ health and life expectancy. But ...